Laminins in the Skin
Laminins in the Skin
批准号:
8067756
负责人:
Matt Peter Marinkovich
金额:
$34.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2014-04-30
关键词:
AddressBindingBiological AssayC-terminalCellsCiliaDataDefectDermalDermatologicDevelopmentDiseaseDrug or chemical Tissue DistributionEpidermisEpithelialEpitheliumEventFundingGrowth FactorGuanosine Triphosphate PhosphohydrolasesHairHair follicle structureHealthHumanImmuneImmune systemImmunologicsImmunoproliferative DisordersInfiltrationInflammatoryIntegrin BindingIntegrin Signaling PathwayIntegrinsLamininMeasuresMediatingMesenchymalModelingMolecularMolecular ProfilingMorphogenesisMusPDGFRB genePTK2 genePathologyPathway interactionsPeptide Signal SequencesPhenotypePoint MutationProcessProductionPsoriasisRoleSignal TransductionSkinSpecificityStagingSystemT-Lymphocyte SubsetsTestingTransgenic MiceUnited StatesWorkWound Healingappendagecytokinehuman diseasein vivointerleukin 20interleukin-22keratinocytemutantoverexpressionresponseskin disordertongue papillatool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Laminins mediate a variety of important processes involving cell-matrix interactions and show a remarkable diversity of tissue distribution and function. Work by our group during the current support cycle implicates an essential role for laminin-511 in hair and appendage morphogenesis in the skin. We have shown that laminin-511 is an epithelial derived molecule, present at the earliest stages of hair development, which acts upon the dermal papilla (DP), allowing it to properly respond to the follicular epithelium during hair follicle elongation. Laminin-511 interacts with 21 integrin to effect signaling changes leading to primary cilia development and noggin expression in the DP, however the details of this process remain poorly understood. The first Aim of the current application seeks to identify and further delineate the sequence of events which take place between laminin-integrin binding and noggin expression during DP maturation. Towards this end we will test our hypothesis that 1321 integrin, through laminin-511 binding, promotes a sequence of events including FAK, ILK and PDGFR activation which promote primary cilia formation ultimately leading to noggin expression and hair development. The second Aim of this application addresses epidermal immuno-proliferation, a major dermatologic problem in the United States. Laminin-integrin binding during wound healing promotes activation of the GTPase Rac1 and is associated with a controlled epidermal proliferation. However, we have shown that overexpression of an activated mutant of Rac1 in transgenic mouse basal epidermis produces an uncontrolled and immune dependent epidermal proliferation with many similarities to the human disease psoriasis. We hypothesize that epidermal Rac1 activation promotes interaction with the immune system through the production of inflammatory cytokines, and amplifies the proliferative response to immune derived growth factors by facilitating Stat3 activation. After more fully characterizing the immunologic phenotype as well as the cytokine expression profile of this model, we will dissect inflammatory and proliferative pathways and determine the cellular triggering factors that induce immunoproliferative disease. These studies will provide a more precise understanding, on a molecular level, of the keratinocyte-immunocyte interactions which produce immuno-proliferative disease pathology, ultimately leading to the development of more specific and less toxic therapies. PUBLIC HEALTH RELEVANCE: Advances derived from this support cycle have led to advances in our understanding of how laminins control epithelial mesenchymal interactions during hair development. The proposed studies in the first Aim will determine the sequence of events which occur in the early events of hair formation. This application also presents preliminary data of a highly promising model of immunoproliferative skin disease resembling the human disease psoriasis. The studies proposed in the second Aim will determine the cellular and molecular interactions, as well as the triggering factors which precipitate epidermal proliferation and immune infiltration in this model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Laminin-332 and its Receptors in Carcinoma Progression
-
批准号:7895866
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2008
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminin-332 and its Receptors in Carcinoma Progression
-
批准号:7686297
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2008
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminin-332 and its Receptors in Carcinoma Progression
-
批准号:7507715
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2008
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminin-332 and its Receptors in Carcinoma Progression
-
批准号:8106326
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2008
-
负责人:Matt Peter Marinkovich
-
依托单位:
Epithelial matrix in carcinoma development
-
批准号:6663339
-
项目类别:
-
资助金额:$17.11万
-
财政年份:2002
-
负责人:Matt Peter Marinkovich
-
依托单位:
ANCHORING FILAMENT ANALYSIS AND CORRECTION IN EPIDERMOLYSIS BULLOSA
-
批准号:6470587
-
项目类别:
-
资助金额:$17.11万
-
财政年份:2001
-
负责人:Matt Peter Marinkovich
-
依托单位:
ANCHORING FILAMENT ANALYSIS AND CORRECTION IN EPIDERMOLYSIS BULLOSA
-
批准号:6348933
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
ALPHA 6 BETA 4 INTEGRIN & LAMININ 5 IN CELL MIGRATION
-
批准号:6648408
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:7059496
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:7867982
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:7227234
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:6825113
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
ALPHA 6 BETA 4 INTEGRIN & LAMININ 5 IN CELL MIGRATION
-
批准号:6533009
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:7730143
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:7414745
-
项目类别:
-
资助金额:$32.77万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:8467994
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:8257146
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
Laminins in the Skin
-
批准号:6914890
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
ALPHA 6 BETA 4 INTEGRIN & LAMININ 5 IN CELL MIGRATION
-
批准号:6375367
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
ALPHA 6 BETA 4 INTEGRIN & LAMININ 5 IN CELL MIGRATION
-
批准号:6193961
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2000
-
负责人:Matt Peter Marinkovich
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: